|
Mutation Information
|
Mutation Site
|
L229V |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Combined Mutation
|
rt.L229V+rt.F221Y |
|
Genotype/Subtype
|
B;C |
|
Relevant Drug
|
lamivudine (LAM);entecavir (ETV);adefovir dipivoxil (ADV) |
|
Country
|
China |
Literature Information
|
PubMed PMID
|
31147594
|
|
Disease
|
HBV infection
|
|
Published Year
|
2019 |
|
Journal
|
Scientific reports |
|
Title
|
Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection. |
|
Author
|
Zhang X,Chen X,Wei M,Zhang C,Xu T,Liu L,Xu Z |
|
Evidence
|
Inthisstudy,non-classicalmutationswereobservedin29patientswhosufferingfromvirologicalbreakthroughandwithoutclassicalmutations(Table.4)at9sites(V191I,V207I/M,S213T,E218D,F221Y,I224V,L229V,N/H238andR242D).
|
|
|
HBV Mutation Detail Information